---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-001751"
form_type: "8-K"
ticker: "TDOC"
cik: "0001477449"
company_name: "Teladoc Health, Inc."
filed_at: "2023-02-22T23:59:59+00:00"
generated_at: "2026-06-19T04:41:25.395497+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Teladoc Health Q4 revenue up 15% to $637.7M; net loss of $3.81B on $3.77B goodwill impairment

## Summary
- Full-year 2022 revenue $2.41B (+18% YoY); net loss $13.66B ($84.60/share) driven by $13.4B non-cash goodwill impairment.
- Q4 adjusted EBITDA $94.1M (+22% YoY); full-year adjusted EBITDA $246.5M (-8% YoY).
- BetterHelp segment Q4 revenue $277.0M (+29% YoY); Integrated Care Q4 revenue $357.1M (+6% YoY).
- Full-year free cash flow $16.5M vs $130.1M in 2021; cash position $918.2M at Dec 31, 2022.
- Q1 2023 revenue guidance $610-625M; full-year 2023 revenue $2.55-2.675B, adjusted EBITDA $275-325M.

## SEC filing metadata
- accession: 0001558370-23-001751
- form_type: 8-K
- ticker: TDOC
- cik: 0001477449
- company_name: Teladoc Health, Inc.
- filed_at: 2023-02-22T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477449/000155837023001751/0001558370-23-001751-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477449/000155837023001751/tdoc-20230222x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-001751
- JSON: https://secwatch.observer/filing/0001558370-23-001751.json
- Plain text: https://secwatch.observer/filing/0001558370-23-001751.txt

## Key facts
- Earnings Releases
  Teladoc Health, Inc. reported Full Year 2022 results: revenue $2,406.8 million, net income ($13,659.5 million), EPS ($84.60) per share.
  - Period: Full Year 2022
  - Revenue: $2,406.8 million
  - Net income: ($13,659.5 million)
  - EPS: ($84.60) per share
  - Result: reported results
  source text: Full Year Ended December 31, 2022 Revenue increased 18% to $2,406.8 million from $2,032.7 million for the year ended December 31, 2022 (“Full-Year 2022”). Access fees revenue grew 21% to $2,103.8 million, and other revenue grew 4% to $303.0 million. U.S. revenues and International revenues each grew 18% to $2,101.0 million and $305.8 million, respectively. Revenue increased 6% to $1,373.9 million for the Integrated Care segment and increased 41% to $1,019.6 million for the BetterHelp segment for Full-Year 2022. Non-cash goodwill impairment charges of $13.4 billion were recorded for Full-Year 2022. The non-cash charges had no impact on the provision for income taxes. Net loss totaled $13,659.5 million, or ($84.60) per share, for the year ended December 31,2022, compared to $428.8 million, or ($2.73) per share, for the year ended December 31, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1477449/000155837023001751/0001558370-23-001751-index.htm
- Earnings Releases
  Teladoc Health, Inc. reported Fourth Quarter 2022 results: revenue $637.7 million, net income ($3,810.1 million), EPS ($23.49) per share.
  - Period: Fourth Quarter 2022
  - Revenue: $637.7 million
  - Net income: ($3,810.1 million)
  - EPS: ($23.49) per share
  - Result: reported results
  source text: Fourth Quarter 2022 Revenue increased 15% to $637.7 million from $554.2 million in the fourth quarter of 2021. Access fees revenue grew 16% to $553.7 million and other revenue grew 10% to $84.0 million. U.S. Revenues grew 15% to $554.4 million and International revenues grew 17% to $83.3 million. Revenue increased 6% to $357.1 million for the Teladoc Health Integrated Care (“Integrated Care”) segment and increased 29% to $277.0 million for the BetterHelp segment in the fourth quarter of 2022. See note (9) in the Notes section that follows for further information regarding segment reporting. Non-cash goodwill impairment charges of $3.8 billion were recorded in the fourth quarter of 2022. The non-cash charges had no impact on the provision for income taxes. Net loss totaled $3,810.1 million, or ($23.49) per share, for the fourth quarter of 2022, compared to $11.0 million, or ($0.07) per share, for the fourth quarter of 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1477449/000155837023001751/0001558370-23-001751-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.